Articles
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Mon. Dec 1, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Mon. Dec 1, 2025: how do you pick a doctor for a second opinion?
Active Surveillance Prostate Cancer Video Chat, November 26th, 2025
Active Surveillance Prostate Cancer Video Chat, November 26th, 2025
Low/Intermediate PCa Video Chat, November 24, 2025
Low/Intermediate PCa Video Chat, November 24, 2025: Manage “buyer’s remorse” by trusting the decision
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 25, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 25, 2025: Robust discussion around testoterone early – and thoughts about combining therapies at the end.
Veterans Video Chat, November 18, 2025
Veterans Video Chat, Novemeber 18, 2025: Maintaining a 100% temporary rating during active treatment and active surveillance
Low/Intermediate PCa Video Chat, November 10, 2025
Low/Intermediate PCa Video Chat, November 10, 2025: Cancel rushed surgery and get a second pathology opinion.
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 17, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 17, 2025: Assessing recurrence and IDC-P repeat this week
Active Surveillance Prostate Cancer Video Chat, November 12th, 2025
Active Surveillance Prostate Cancer Video Chat, November 12th, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 11, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat: Can abiraterone impact your hearing?
Low/Intermediate PCa Video Chat, October 27, 2025
Low/Intermediate PCa Video Chat, October 27, 2025: Treatment recommendations including whole-gland radiation versus active surveillance.
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 3, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 3, 2025: High volume de novo metastatic diagnosis calls for triplet therapy.
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct 28, 2025
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct 20, 2025: Unpredictable & outstanding response to surgery for G4+5 man